Research at Butler Hospital

An observational study will evaluate the feasibility of using app-based brain games to assess cognitive function over several days using a smartphone.

An observational study aims to understand what changes to the retina can detect Alzheimer’s risk before memory symptoms occur.

A Phase III, double-blinded, placebo-controlled study with a treatment arm. Eligible participants will be randomly assigned to receive either the investigational medication, BAN2401, or placebo.

A two-year clinical trial to test whether lifestyle interventions that target multiple risk factors protect cognitive function in older adults at increased risk for cognitive decline.

A 5 year observational study that requires participants to undergo a variety of exams to determine the relationships between various characteristics of the Alzheimer’s disease spectrum.

An observational study exploring the development of early-onset Alzheimer’s disease and how it compares to the more common late-onset Alzheimer’s disease.

A longitudinal, observational study for individuals in ADAD families. ADAD is a genetic mutation that typically causes memory loss and dementia in the 30s to 50s.

An 18-month, randomized, double-blind study for people who have a diagnosis of MCI or mild AD.

A study for individuals in early recovery from opioid use and taking the medication buprenorphine (suboxone). Participants will engage in 5 sessions of active or placebo transcranial direct stimulation (tDCS) during the course of this 2-week study.

Research Investigating Stimulation for Extinction in PTSD.